美女免费一级视频在线观看

HCP engagement is what established Relevate Health as a competitive player in medical marketing and remains an area the agency prioritizes.

According to CEO Tim Pantello, Relevate isn’t here to “sell you more things” but rather to help its clients achieve better outcomes. 

How that’s done is through omnichannel activations with precision targeting of HCPs, continued investment in its ELE data platform as well as the deployment of AI-powered solutions across content creation, data processing and analytics.

With that mission in mind, all signs pointed north for Relevate in 2024. The independent agency’s revenue rose to $84.4 million and its head count increased to 220 employees.

Not one to rest on its laurels, the agency sought to build off its momentum and lean into the dynamic health content space.

While Relevate has long focused on opportunities in POC marketing, it also took action to enter the world of medical video games. 

In September, Relevate purchased the pharma and life sciences unit of Level Ex, which develops video games for physicians, from German medical device maker Brainlab.

Chief business officer Michael Cole says the value of the acquisition comes from owning a piece of immersive, interactive content that goes beyond traditional advertising methods — allowing for deeper engagement and richer data collection about HCPs.

“Our ability — that knowledge graph that we have of doctors — is where [Level Ex] fits into our story incredibly well,” he says. 

That expertise with effectively reaching the target HCP audience is what clients keep coming back for more, too.

Tricia Brody, director, lead of payer marketing and strategy at Chiesi GRD, says its Filsuvez team began working with Relevate at the end of 2023. She says the team will continue the partnership through 2025 and beyond as part of an upcoming U.S. market access launch for a rare disease product. This is largely because Relevate’s market access team was quick to engage as a strategic and tactical partner. 

“In our after-action reviews, the larger cross-functional team (PRB included) has provided feedback on how they appreciated working with Relevate from a market access, brand, medical and regulatory perspective,” she says. “So much so that medical and brand have initiated separate workstreams with Relevate.” 

Additionally, Jeff Olivo, associate director of marketing at AstraZeneca, commends Relevate as being proactive, insightful and helpful throughout the process of executing its proprietary PracticeShare program. 

“They have also been thought partners with us, not just trying to sell us ideas, but working with us to think through possible solutions for how we can overcome our brand’s challenges,” Olivo says. 

Reflecting on last year, Pantello remarks that the most significant learning is how agencies can operationalize their services into solutions. He also credits the move from offering subjective creativity to objective outcome-driven results as driving the agency’s success and helping it stand out.

Being on the other side of that transition, he’s at peace with the agency’s standing.

“I would posit to say that I would rather be us than anyone else on your list,” he says. 

One insight from a consumer campaign to apply to medical marketing

Vanguard continues to run campaigns in all channels we believe healthcare can learn from. What impresses us most is how it continues to connect simplicity to outcomes. It is easy to lean into the buzzwords and jargon in objectively complex categories. It is equally easy to lean into your “special sauce” or unique approach. What we find refreshing and, frankly, most impactful is when you put simplicity and transparency front and center and connect your way of work to the customer end benefit. — Michael Cole 

Click to see Relevate Health’s Agency 100 2024 Profile.

Click here to return to the MM+M Agency 100.

From the June 01, 2025 Issue of MM+M - Medical Marketing and Media